Search for: "HH" Results 841 - 860 of 9,469
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 Dec 2022, 12:29 pm by Brittney Cafero
The National Committee on Vital and Health Statistics recommended in an April 2020 letter that HHS publish a proposed rule to address evolving industry changing business needs. [read post]
27 Mar 2011, 9:20 pm by Ben Vernia
Although the OIG-HHS operates the hotline, it forwards the information it receives to CMS for handling. [read post]
21 Apr 2012, 5:05 pm by Rachel Grunberger
By Anna Kraus and Rachel Grunberger The Department of Health and Human Services (HHS) announced on Tuesday that Phoenix Cardiac Surgery, P.C. [read post]
17 Jan 2013, 4:12 pm by Rachel Grunberger
  The omnibus rule is comprised of the following four rules: Final modifications to the HIPAA regulations mandated by the HITECH Act, and certain other modifications to improve the HIPAA rules; Final rule adopting changes to the HIPAA Enforcement Rule; Final rule on Breach Notification for Unsecured Protected Health Information under the HITECH Act, which, according to HHS, replaces the current rule’s “risk of harm” threshold with a more objective standard; and Final… [read post]
27 Jul 2012, 8:21 am
The case of HH v BLW [2012] EWHC 2199 (Fam), reported today on Bailli, deals with the rare instance of a costs order made in private law children proceedings. [read post]
12 Jul 2010, 9:55 pm by Ben Vernia
On June 8, the Office of Inspector General of HHS announced a settlement with three Chicago-based physician-owned businesses to pay $7.3 million in Civil Monetary Penalties. [read post]
10 Oct 2013, 4:08 am by Debra A. McCurdy
On September 25, 2013, HHS published a proposed rule that would establish the Basic Health Program, as required by section 1331 of the ACA. [read post]
4 Nov 2014, 5:14 am by Debra A. McCurdy
The OIG plans numerous reviews of CMS, FDA, and other HHS agency programs, with a particular focus on Medicare and Medicaid reimbursement and program integrity policies. [read post]
25 Oct 2020, 10:00 pm
The US Department of Health and Human Services (HHS) issued two welcome announcements on October 22 relating to the CARES Act Relief Fund Provider Relief Fund (PRF). [read post]
14 Sep 2020, 10:00 pm
Our FDA team recently posted a LawFlash about the US Department of Health and Human Services (HHS) August 19 announcement, Rescission of Guidances and Other Informal Issuances Concerning Premarket Review of Laboratory Developed Tests, in which it stated that the FDA would not require premarket review of laboratory developed tests (LDTs) without notice-and-comment rulemaking. [read post]
25 Oct 2020, 10:00 pm
The US Department of Health and Human Services (HHS) issued two welcome announcements on October 22 relating to the CARES Act Relief Fund Provider Relief Fund (PRF). [read post]
25 Oct 2020, 10:00 pm
The US Department of Health and Human Services (HHS) issued two welcome announcements on October 22 relating to the CARES Act Relief Fund Provider Relief Fund (PRF). [read post]
25 Oct 2020, 10:00 pm
The US Department of Health and Human Services (HHS) issued two welcome announcements on October 22 relating to the CARES Act Relief Fund Provider Relief Fund (PRF). [read post]
14 Sep 2020, 10:00 pm
Our FDA team recently posted a LawFlash about the US Department of Health and Human Services (HHS) August 19 announcement, Rescission of Guidances and Other Informal Issuances Concerning Premarket Review of Laboratory Developed Tests, in which it stated that the FDA would not require premarket review of laboratory developed tests (LDTs) without notice-and-comment rulemaking. [read post]
25 Oct 2020, 10:00 pm
The US Department of Health and Human Services (HHS) issued two welcome announcements on October 22 relating to the CARES Act Relief Fund Provider Relief Fund (PRF). [read post]
14 Sep 2020, 10:00 pm
Our FDA team recently posted a LawFlash about the US Department of Health and Human Services (HHS) August 19 announcement, Rescission of Guidances and Other Informal Issuances Concerning Premarket Review of Laboratory Developed Tests, in which it stated that the FDA would not require premarket review of laboratory developed tests (LDTs) without notice-and-comment rulemaking. [read post]